Robert Shepard

Phase I/II Trial of Nanomolecular Liposomal Annamycin in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Meir Wetzler, D. A. Thomas, Eunice S. Wang et al. · Clinical Lymphoma Myeloma & Leukemia · 2013 · 45 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Phase II Study of Gemcitabine in Combination with Docetaxel in Patients with Advanced Pancreatic Carcinoma (E1298)

Robert Shepard, Donna E. Levy, Jordan Berlin et al. · Oncology · 2004 · 34 citations

Medicine, Oncology, Pharmacology +13

Thalidomide Plus Dexamethasone Versus Dexamethasone Alone in Newly Diagnosed Multiple Myeloma (E1A00): Results of a Phase III Trial Coordinated by the Eastern Cooperative Oncology Group.

S. Vincent Rajkumar, Emily Blood, David H. Vesole et al. · Blood · 2004 · 29 citations

Medicine, Hematology, Oncology +11

A randomised phase III trial of thalidomide plus dexamethasone versus dexamethasone in newly diagnosed multiple myeloma (E1A00): A trial coordinated by the Eastern Cooperative Oncology Group

S. Vincent Rajkumar, Emily Blood, David H. Vesole et al. · Journal of Clinical Oncology · 2004 · 21 citations

Medicine, Hematology, Pharmacotherapy +9

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Sonja Althammer, Keith E. Steele, Marlon C. Rebelatto et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text

Medicine, Immunology, Oncology +17